Know Cancer

or
forgot password


N/A
N/A
N/A
Open (Enrolling)
Both
Leukemia, Myeloid, Chronic

Thank you

Trial Information


Inclusion Criteria:



- Patients with CML

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Outcome Measure:

safety and efficacy

Outcome Time Frame:

10 years

Safety Issue:

No

Principal Investigator

Naeeem Chaudhri, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

King Faisal Specialist Hospital & Research Centre

Authority:

United States: Institutional Review Board

Study ID:

RAC #2051-056

NCT ID:

NCT00538447

Start Date:

June 2007

Completion Date:

June 2020

Related Keywords:

  • Leukemia, Myeloid, Chronic
  • CML
  • Leukemia
  • Leukemia, Myeloid
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Name

Location